NUGL Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUGL research report →
About the company
NUGL Inc. operates as a fully integrated medical cannabis business. The company manages cultivation and processing facilities, along with three retail dispensaries.
- CEO
- Balram Vaswani
- IPO
- 2002
- Employees
- 12
- HQ
- Chino, CA, US
Price Chart
- Market Cap
- $1.44M
- P/E
- 17.00
- P/S
- 0.40
- P/B
- 0.92
- EV/EBITDA
- -18.63
- Div Yield
- 0.00%
- Gross Margin
- 45.96%
- Op Margin
- -9.85%
- Net Margin
- -16.56%
- ROE
- -34.90%
- ROIC
- -10.25%
- Revenue
- $2.97M · 27.43%
- Net Income
- $-212,000 · 74.43%
- EPS
- $-0.00 · 77.78%
- Op Income
- $-582,000
- FCF YoY
- -118.31%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.41
- Avg Volume
- 1.22M
Get TickerSpark's AI analysis on NUGL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NUGL coverage
Recent articles, reports, and earnings notes.
No research on NUGL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NUGL report →Similar companies
Peers in the same neighborhood.